Author:
Vendel-Zwaagstra Annabel,Hilkens John
Reference170 articles.
1. Acha-Orbea, H., & MacDonald, H. R. (1995). Superantigens of mouse mammary tumor virus. Annual Reviews of Immunology, 13, 459–486.
2. Andrechek, E. R., Laing, M. A., Girgis-Gabardo, A. A., Siegel, P. M., Cardiff, R. D., & Muller, W. J. (2003). Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers. Cancer Research, 63, 4920–4926.
3. Androutsellis-Theotokis, A., Leker, R. R., Soldner, F., Hoeppner, D. J., Ravin, R., Poser, S. W., et al. (2006). Notch signalling regulates stem cell numbers in vitro and in vivo. Nature, 442, 823–826.
4. Ayyanan, A., Civenni, G., Ciarloni, L., Morel, C., Mueller, N., Lefort, K., et al. (2006). Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proceedings of the National Academy of Sciences USA, 103, 3799–3804.
5. Ball, J. K., Diggelmann, H., Dekaban, G. A., Grossi, G. F., Semmler, R., Waight, P. A., et al. (1988). Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus. Journal of Virology, 62, 2985–2993.